Glen Eagle Advisors’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-100
| Closed | -$715 | – | 1031 |
|
|
2020
Q4 | $715 | Hold |
100
| – | – | ﹤0.01% | 926 |
|
|
2020
Q3 | $1.07K | Hold |
100
| – | – | ﹤0.01% | 842 |
|
|
2020
Q2 | $1.26K | Hold |
100
| – | – | ﹤0.01% | 796 |
|
|
2020
Q1 | $915 | Hold |
100
| – | – | ﹤0.01% | 761 |
|
|
2019
Q4 | $1.4K | Hold |
100
| – | – | ﹤0.01% | 813 |
|
|
2019
Q3 | $1.72K | Hold |
100
| – | – | ﹤0.01% | 719 |
|
|
2019
Q2 | $2.72K | Hold |
100
| – | – | ﹤0.01% | 674 |
|
|
2019
Q1 | $1.91K | Sell |
100
-125
| -56% | -$2.39K | ﹤0.01% | 657 |
|
|
2018
Q4 | $2.12K | Hold |
225
| – | – | ﹤0.01% | 622 |
|
|
2018
Q3 | $4.26K | Buy |
+225
| New | +$4.26K | ﹤0.01% | 581 |
|
|
2017
Q3 | – | Sell |
-500
| Closed | -$4.48K | – | 656 |
|
|
2017
Q2 | $4.48K | Hold |
500
| – | – | ﹤0.01% | 486 |
|
|
2017
Q1 | $6.62K | Hold |
500
| – | – | 0.01% | 428 |
|
|
2016
Q4 | $6.37K | Buy |
+500
| New | +$6.37K | 0.01% | 414 |
|